The objective of present work is to investigate the enhancement of dissolution profile for oral delivery of Fexofenadine Hydrochloride (FH) through solid dispersion (SD) technique by the method of solvent evaporation. The SD was prepared by using ethanol as a solvent. Tablets were formulated containing solid dispersion of FH and compared with tablets of same formula without solid dispersion of FH. The using of ethanol to prepare solid dispersion found a significant effect on the dissolution of FH. Dissolution studies using the USP-33 paddle method were performed for tablets formulated with and without solid dispersions of FH. Dissolution of FH improved significantly in tablets formulated with SD (85% in 10 minutes) exhibited better dissolution profile than tablets formulated without SD. Infrared (IR) spectroscopy was also performed to identify the physicochemical interaction between drug and solvent, hence its effect on dissolution.
INTRODUCTION
Fexofenadine Hydrochloride, a selective peripheral H 1 receptor antagonist, is a potent antihistamine drug that is indicated for seasonal allergic rhinitis and chronic idiopathic urticaria (Vena et al., 2002) . According to British Pharmacopoeia' 2009, it is slightly soluble in water. Its slight solubility makes its absorption, dissolution rate limited and thus delays onset of action. One of the major current challenges of pharmaceutical sciences is to enhancement of the solubility of poorly water soluble drugs.
Over the years, a number of techniques have been developed to improve the dissolution of poorly water soluble drugs, such as inclusion complexation, salt formation, and cogrinding (Anzai et al., 2007; Ki et al., 2007; Barzegar-Jalali et al., 2006) . Among other techniques, solid dispersion (SD) is one of the popular methods to enhance the solubility and dissolution rate of poorly water soluble drugs (Pouton, 2006) . In SD technique, the particle size of drugs is reduced from crystalline to microcrystalline or molecular state (Wang et al., 2005) . This leads to the enhancement of the solubility.
To prepare SD of drug, there are three major methods as melting method, solvent method and solvent evaporation method. Among these three methods, melting method and solvent method have some drawbacks. Melting method requires high temperature which may result in the decomposition of drug. In solvent method, the issue of difficulty in selection of common volatile solvents arises coupled with chemical instability of drugs (Kim et al., 2006) . In this study, SD was prepared by solvent evaporation method without using any career. After assessing the drug content of the solid dispersion, the products were characterized by Infrared (IR) spectroscopy and in-vitro dissolution study.
MATERIALS AND METHODS

Materials:
Fexofenadine Hydrochloride (FH) was a gift sample from Id-swift Laboratories ltd, India. Microcrystalline Cellulose (Avicel PH 102) was purchased from Veer Pharma Chem, India. Sodium Starch Glycolate and Magnesium Stearate were supplied from Chemical Management Co., Germany.
Methods
Preparation of matrix tablets with SD of FH: Solid dispersion of FH was prepared by using solvent evaporation method. FH was dispersed in an appropriate amount of ethanol (2 times the total weight of drug). After smooth dispersion was prepared; it was transferred into a container. The solvent was evaporated at 45°C and resulting residue was dried in hot air oven for one hour and stored for 24 hours in a desiccators. Subsequently, the dispersion was passed through sieve no. 40. After sieving, this SD was mixed thoroughly with diluents Microcrystalline Cellulose (Avicel PH 102) and disintegrating agents Sodium Starch Glycolate. Then the lubricant Magnesium Stearate was added to the powder mix and powder mix was passed through sieve no. 40 and mixed well. Then the powder mix is compressed using a Shimadzu laboratory hydraulic press equipped with 10 mm round punch, die set. Then the powder mix is compressed using a Shimadzu laboratory hydraulic press equipped with 10 mm round punch, die set. The formulation of matrix tablets without SD of FH was termed as F-2.
Solid state studies Fourier Transform Infrared (FTIR) spectroscopy:
FTIR spectra were recorded on samples prepared in potassium bromide (KBr) discs using a Shimadzu FTIR 8000 series spectrophotometer (Tokyo, Japan). Samples were prepared in KBr discs by means of a hydrostatic press. The scanning range was from 400 cm -1 to 2000 cm -1 and the resolution was 4 cm -1 .
In-vitro dissolution studies: Dissolution studies were performed in 900 ml 0.001 N HCl at 37 ± 0.5 ο C, using 6-station USP Electro Lab Tablet Dissolution Test Machine (XXII); with paddle rotating at 50 rpm. Products of both formulations (F-1 & F-2), each containing 120 mg of drug were subjected to dissolution. At fixed time intervals (after 10 and 30 minutes), samples withdrawn were filtered (pore size 0.22 μm) and spectrophotometrically assayed for drug content at 220 nm according to the dissolution procedure of United States Pharmacopoeia (32 th Edition).
Evaluation of tablets:
The prepared matrix tablets were evaluated for weight variation, hardness, thickness, friability and drug content. Hardness of the tablets was tested using a strong-Cobb hardness tester (Tab-Machine, Mumbai). Friability of the tablets was determined in a Roche friabilator (Campbell Electronics, Mumbai). The thickness of the tablets was measured by vernier calipers. Weight variation test was performed according to the official method of British Pharmacopoeia. Drug content for FH was carried out according to assay procedure of United States Pharmacopoeia (32 th Edition).
RESULTS AND DISCUSSION Fourier Transform Infrared (FTIR) spectroscopy:
IR spectra of FH and its SD system were presented in Figure-1 . Pure FH spectra showed sharp characteristic peaks at 1710, 1440, 1275, 1180, 1060, 960, 825, 750 and 705 cm -1 . All the above characteristic peaks appear in the spectra of SD system at same wave number indicating no modification or interaction between the drug and solvent.
Physical parameters study:
The results of physical parameters i.e. weight, hardness, thickness and friability as well as drug content of the prepared matrix tablets for both formulations was shown in Table- 2. The hardness of tablets found ranges from 8.0 ± 0.02 kg/cm 2 to 8.1 ± 0.02 kg/cm 2 and friability ranges from 0.13% to 0.15% respectively. The tablet formulations in all the prepared batches contained FH within 94% to 100% of labeled content. All tablets complied with the specifications of pharmacopoeia standards for weight variation and friability. In-vitro dissolution studies: Table-3 shows data analysis of release profiles at different time points (10 min, 30 min). The drug release from F-1 was over 85% after 10 minutes where drug release from F-2, only 56.23% after 10 minutes. Sequentially drug release from F-1 after 30 minutes was 96.91% which is higher than that of F-2, only 71.24%. So the solid dispersion technique has improved the dissolution of FH from its matrix tablets to a greater extent. The technique that has been useful in that dissolution of poorly water soluble drugs is the use of suitable volatile solvent to prepare SD of FH. When solvent evaporates properly from the solid dispersion, the dispersed drug being lack of crystallinity i.e. amorphization, increased wettability as well as dispersibility and particle size reduction considered to be important factors for dissolution rate enhancement. Because dry mixing of SD with other excipients results in greater wetting and increases surface available for dissolution as it reduces the interfacial tension between hydrophobic drug and dissolution media. 
CONCLUSION
This study shows that the dissolution rate of FH can be enhanced to a greater extent through solid dispersion by using an industrially feasible solvent evaporation technique. Hence this process can be considered for the formulation matrix tablet of various poorly water soluble drugs for rapid and high dissolution rate as well as high oral absorption and bioavailability.
